Alessandro Borghesi Selected Research

Cytochrome B-Negative Autosomal Recessive Chronic Granulomatous Disease

1/2022

Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Borghesi Research Topics

Disease

9	Sepsis (Septicemia) 05/2018 - 01/2007
5	Infections 01/2022 - 10/2011
3	COVID-19 02/2024 - 06/2022
2	Pneumonia (Pneumonitis) 02/2024 - 06/2022
2	Invasive Fungal Infections 06/2013 - 10/2011
1	Lung Diseases (Lung Disease) 12/2023
1	Encephalitis (Encephalitis, Rasmussen) 01/2023
1	West Nile Fever 01/2023
1	Myocarditis (Carditis) 10/2022
1	Breakthrough Infections 06/2022
1	Keratitis 01/2022
1	Chronic Granulomatous Disease 01/2022
1	Macrophage Activation Syndrome 01/2022
1	Neoplasms (Cancer) 01/2022
1	Histiocytosis 01/2022
1	Necrotizing Pneumonia 01/2022
1	Cytochrome B-Negative Autosomal Recessive Chronic Granulomatous Disease 01/2022
1	Autistic Disorder (Autism) 06/2021
1	Refractive Errors (Refractive Error) 10/2017
1	Birth Weight (Birth Weights) 06/2013
1	Mycoses (Diseases, Fungus) 06/2013
1	Newborn Respiratory Distress Syndrome 01/2013
1	Premature Birth (Birth, Premature) 01/2013
1	Diseases Newborn Infant 01/2013
1	Neonatal Sepsis 10/2011
1	Virus Diseases (Viral Diseases) 08/2011
1	Chronic Mucocutaneous Candidiasis 08/2011
1	Streptococcal Infections (Streptococcal Infection) 01/2009
1	Precocious Puberty 10/2003

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 02/2024 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2011
3	AntibodiesIBA 01/2023 - 05/2018
2	mRNA VaccinesIBA 10/2022 - 06/2022
2	VaccinesIBA 06/2022 - 06/2021
2	SteroidsIBA 01/2022 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 05/2018 - 02/2013
2	Fluconazole (Zonal)FDA LinkGeneric 06/2013 - 10/2011
2	LactoferrinIBA 06/2013 - 10/2011
1	ORALIT (ORS)IBA 02/2024
1	Messenger RNA (mRNA)IBA 12/2023
1	Chemokine ReceptorsIBA 12/2023
1	COVID-19 VaccinesIBA 06/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Polysaccharides (Glycans)IBA 05/2018
1	HydrogelsIBA 10/2017
1	SiliconesIBA 10/2017
1	Neutralizing AntibodiesIBA 01/2017
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	Anti-Infective Agents (Microbicides)IBA 04/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2014
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2014
1	Oxygen (Dioxygen)IBA 06/2013
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 02/2013
1	Surface-Active Agents (Surfactants)IBA 01/2013
1	Immunoglobulins (Immunoglobulin)IBA 10/2011
1	Heparin (Liquaemin)FDA LinkGeneric 10/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 10/2011
1	Interleukin-27 (Interleukin 27)IBA 08/2011
1	Interleukin-17 (Interleukin 17)IBA 08/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2003
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2003

Therapy/Procedure

3	Therapeutics 04/2015 - 01/2013
2	Antibiotic Prophylaxis 03/2014 - 01/2007
2	Chemoprevention 10/2011 - 01/2009
1	Contact Lenses 01/2022
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 10/2017
1	Duration of Therapy 04/2015
1	Central Venous Catheters 10/2011
1	Hand Hygiene 10/2011